anacin

Generic: asprin and caffeine

Labeler: insight pharmaceuticals llc
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name anacin
Generic Name asprin and caffeine
Labeler insight pharmaceuticals llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

aspirin 400 mg/1, caffeine 32 mg/1

Manufacturer
Insight Pharmaceuticals LLC

Identifiers & Regulatory

Product NDC 63736-200
Product ID 63736-200_4895609d-1ec8-4ebd-8b6e-61ccd452ad5b
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M013
Listing Expiration 2026-12-31
Marketing Start 2009-06-25

Pharmacologic Class

Established (EPC)
nonsteroidal anti-inflammatory drug [epc] platelet aggregation inhibitor [epc] central nervous system stimulant [epc] methylxanthine [epc]
Mechanism of Action
cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs] xanthines [cs]
Physiologic Effect
decreased prostaglandin production [pe] decreased platelet aggregation [pe] central nervous system stimulation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 63736200
Hyphenated Format 63736-200

Supplemental Identifiers

RxCUI
198479 211292
UNII
R16CO5Y76E 3G6A5W338E
NUI
N0000000160 N0000008836 M0001335 N0000175722 N0000175578 N0000008832 N0000175739 N0000175729 N0000175790 M0023046

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name anacin (source: ndc)
Generic Name asprin and caffeine (source: ndc)
Application Number M013 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 400 mg/1
  • 32 mg/1
source: ndc
Packaging
  • 1 BOTTLE in 1 BOX (63736-200-90) / 100 TABLET in 1 BOTTLE
  • 1 BOTTLE in 1 BOX (63736-200-93) / 300 TABLET in 1 BOTTLE
source: ndc

Packages (2)

Ingredients (2)

aspirin (400 mg/1) caffeine (32 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4895609d-1ec8-4ebd-8b6e-61ccd452ad5b", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "unii": ["R16CO5Y76E", "3G6A5W338E"], "rxcui": ["198479", "211292"], "spl_set_id": ["51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Insight Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 BOX (63736-200-90)  / 100 TABLET in 1 BOTTLE", "package_ndc": "63736-200-90", "marketing_start_date": "20090625"}, {"sample": false, "description": "1 BOTTLE in 1 BOX (63736-200-93)  / 300 TABLET in 1 BOTTLE", "package_ndc": "63736-200-93", "marketing_start_date": "20090625"}], "brand_name": "Anacin", "product_id": "63736-200_4895609d-1ec8-4ebd-8b6e-61ccd452ad5b", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "63736-200", "generic_name": "Asprin and Caffeine", "labeler_name": "Insight Pharmaceuticals LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Anacin", "active_ingredients": [{"name": "ASPIRIN", "strength": "400 mg/1"}, {"name": "CAFFEINE", "strength": "32 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20090625", "listing_expiration_date": "20261231"}